SGS, a leading life sciences pharmaceutical clinical and bioanalytical contract solutions provider, will host a complimentary Biopharm Day in Antwerp, Belgium.

The event, building on the success of previous years, will be held at the Lindner Hotel on Tuesday October 25, 2016.

This one day conference, entitled “Bridging Early to Late Phase Clinical Trials, from Volunteers to Patients” will bring together experts from SGS's Clinical Research Services and the wider pharmaceutical industry, to discuss advances in biopharmaceutical research and development and combine a number of scientific talks, case studies and face-to-face meetings to highlight the most recent solutions in clinical development optimization.

Joining SGS experts will be industry consultant Maarten Van Doorslaer, who will discuss rules, tips and tricks for maximizing regional and European R&D funding for clinical trials; Filip Goossens, Senior Business & Investment Manager at Sopartec who will cover how regulators perceive the risk today for a new Compound; and Dr. Sofia Côrte-Real, R&D Director of TechnoPhage, SA, who will examine how small to mid-size biotech companies develop innovative therapies and what their expectations are from a CRO.

A tour of SGS Clinical Pharmacology Unit will be organized following the closing remarks.

“This event, now in its fifth year, continues to grow and become more successful, as it gives an opportunity for open discussion on the challenges and opportunities which face both sponsors and service providers in early phase,” commented Jean-Luc Marsat, Managing Director for SGS Clinical Research. “By enabling leading industry experts to share experiences and knowledge in an open forum with clients and other researchers, trends and practices can be identified to benefit all stakeholders within the industry.”

More information about the event, a full program and registration details can be found at: 5th Antwerp Biopharm Day

SGS provides Phase I to IV clinical trial management and services, encompassing data management and statistics, PK/PD modelling and simulation, pharmacovigilance and regulatory consultancy. In addition to its clinical research services, SGS leverages its wholly-owned global network, with 21 laboratories offering contract analytical and bioanalytical services. These laboratories are present in North America, Europe, and Asia, and deliver harmonized solutions to large pharmaceutical and biotechnology firms. 

For further information, please contact:

Florent Hediard
Life Sciences – Marketing Director
Agriculture, Food and Life
SGS, 29 av A. Briand, 94111 Arcueil, France
t: +33 (0) 1 41 24 84 95

Richard Kerns
t: +44 (0)161 728 5880

About SGS

SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 85,000 employees, SGS operates a network of over 1,800 offices and laboratories around the world.